These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8141340)

  • 1. Effects of vasoactive intestinal peptide on myocardial performance.
    Xenopoulos NP; Applegate RJ
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H399-405. PubMed ID: 8141340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagal nerve stimulation during muscarinic and beta-adrenergic blockade causes significant coronary artery dilation.
    Feliciano L; Henning RJ
    J Auton Nerv Syst; 1998 Jan; 68(1-2):78-88. PubMed ID: 9531447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate.
    Henning RJ; Feliciano L; Coers CM
    Cardiovasc Res; 1996 Nov; 32(5):846-53. PubMed ID: 8944815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
    Feliciano L; Henning RJ
    Cardiovasc Res; 1998 Oct; 40(1):45-55. PubMed ID: 9876316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart.
    Shvilkin A; Danilo P; Chevalier P; Chang F; Cohen IS; Rosen MR
    Cardiovasc Res; 1994 Dec; 28(12):1769-73. PubMed ID: 7867028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
    Rigel DF; Lathrop DA
    Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial influence of vasoactive intestinal peptide on ventriculovascular coupling in closed-chest dogs.
    Colston JT; Freeman GL
    Am J Physiol; 1992 Oct; 263(4 Pt 2):H1300-5. PubMed ID: 1415777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vasoactive intestinal polypeptide on heart rate in relation to vagal cardioacceleration in conscious dogs.
    Roossien A; Brunsting JR; Nijmeijer A; Zaagsma J; Zijlstra WG
    Cardiovasc Res; 1997 Feb; 33(2):392-9. PubMed ID: 9074704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate.
    Henning RJ
    J Auton Nerv Syst; 1992 Sep; 40(2):121-9. PubMed ID: 1464693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
    Cheng CP; Noda T; Nordlander M; Ohno M; Little WC
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1232-41. PubMed ID: 8138936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vagal stimulation on left ventricular systolic and diastolic performance.
    Xenopoulos NP; Applegate RJ
    Am J Physiol; 1994 Jun; 266(6 Pt 2):H2167-73. PubMed ID: 8023978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagal-induced tachycardia: release of vasoactive intestinal peptide and peptide HI.
    Anderson FL; Kralios AC; Cluff N; Hanson GR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H2019-24. PubMed ID: 7977833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagal stimulation attenuates sympathetic enhancement of left ventricular function.
    Henning RJ; Khalil IR; Levy MN
    Am J Physiol; 1990 May; 258(5 Pt 2):H1470-5. PubMed ID: 2337181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic hypotensive effect of vasoactive intestinal polypeptide and alpha-blockade with phentolamine. Evidence for vasoactive intestinal peptide alpha-adrenoceptor coupling in the cardiovascular system of newborn dogs.
    Mas MS; Adams DJ; Gelband H
    Circ Res; 1990 Oct; 67(4):986-92. PubMed ID: 2170054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intracavernous simultaneous injection of acetylcholine and vasoactive intestinal polypeptide on canine penile erection.
    Takahashi Y; Aboseif SR; Benard F; Stief CG; Lue TF; Tanagho EA
    J Urol; 1992 Aug; 148(2 Pt 1):446-8. PubMed ID: 1635155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog.
    Hill MR; Wallick DW; Mongeon LR; Martin PJ; Levy MN
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1467-72. PubMed ID: 7485582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside.
    Vatner SF; Higgins CB; Patrick T; Franklin D; Braunwald E
    J Clin Invest; 1971 Dec; 50(12):2585-95. PubMed ID: 5129310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide: electrophysiologic activity in the newborn heart.
    Pickoff AS; Wang SN; Stolfi A; Ramage D; Ross-Ascuitto NT; Kydon DW; Ascuitto RJ
    Pediatr Res; 1994 Feb; 35(2):244-9. PubMed ID: 8165061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated myocardial relaxation in conscious dogs during acute cardiac tamponade.
    Nishikawa Y; Roberts JP; Talcott MR; Dysko RC; Tan P; Klopfenstein HS
    Am J Physiol; 1994 May; 266(5 Pt 2):H1935-43. PubMed ID: 8203592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.
    Unwin RJ; Reed T; Thom S; Calam J; Peart WS
    Br J Clin Pharmacol; 1987 May; 23(5):523-8. PubMed ID: 3297124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.